cicletanine has been researched along with Hypertension, Pulmonary in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cornett, G; Lawler, L; Waxman, AB | 1 |
Rabinovitch, M; Stenmark, KR | 1 |
Ewert, R; Felix, S; Opitz, C; Schlag, K; Wensel, R | 1 |
Arnaud, A; Levy, S; Paganelli, F; Philip-Joët, F; Saadjian, A | 1 |
1 review(s) available for cicletanine and Hypertension, Pulmonary
Article | Year |
---|---|
Emerging therapies for the treatment of pulmonary hypertension.
Topics: Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Apoptosis; Disease Models, Animal; Humans; Hypertension, Pulmonary; Nitric Oxide Synthase; Protein Kinase Inhibitors; Pyridines; rho-Associated Kinases; Vasoactive Intestinal Peptide | 2010 |
1 trial(s) available for cicletanine and Hypertension, Pulmonary
Article | Year |
---|---|
Long-term effects of cicletanine on secondary pulmonary hypertension.
Topics: Antihypertensive Agents; Carbon Dioxide; Double-Blind Method; Hemodynamics; Humans; Hypertension, Pulmonary; Lung Diseases, Obstructive; Male; Middle Aged; Oxygen; Placebos; Pyridines | 1998 |
2 other study(ies) available for cicletanine and Hypertension, Pulmonary
Article | Year |
---|---|
Cicletanine for the treatment of pulmonary arterial hypertension.
Topics: Adult; Antihypertensive Agents; Fatal Outcome; Female; Humans; Hypertension, Pulmonary; Pyridines | 2008 |
[Pulmonary hypertension in hereditary haemorrhagic teleangiectasia (Rendu-Osler-Weber disease). Progression over 10 years].
Topics: Anticoagulants; Antihypertensive Agents; Bosentan; Calcium Channel Blockers; Diuretics; Endothelin Receptor Antagonists; Epistaxis; Epoprostenol; Female; Furosemide; Humans; Hypertension, Pulmonary; Iloprost; Middle Aged; Nifedipine; Pedigree; Phenprocoumon; Pyridines; Sulfonamides; Telangiectasia, Hereditary Hemorrhagic; Treatment Failure; Vasodilator Agents | 2005 |